Saori Suzuki
Otsu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Long-term efficacy of an inactivated H5N1 whole-particle influenza vaccine in nonhuman primates.
Journal: NPJ vaccines
Published: March 13, 2025
Assessing the pyrogenicity of whole influenza virus particle vaccine in cynomolgus macaques.
Journal: Vaccine
Published: December 28, 2021
Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells.
Journal: Vaccine
Published: December 07, 2020
Efficacy of a Cap-Dependent Endonuclease Inhibitor and Neuraminidase Inhibitors against H7N9 Highly Pathogenic Avian Influenza Virus Causing Severe Viral Pneumonia in Cynomolgus Macaques.
Journal: Antimicrobial agents and chemotherapy
Published: August 23, 2020
Immune profiling of influenza-specific B- and T-cell responses in macaques using flow cytometry-based assays.
Journal: Immunology and cell biology
Published: June 12, 2020
Efficacy of Neuraminidase Inhibitors against H5N6 Highly Pathogenic Avian Influenza Virus in a Nonhuman Primate Model.
Journal: Antimicrobial agents and chemotherapy
Published: December 24, 2019
Low replicative fitness of neuraminidase inhibitor-resistant H7N9 avian influenza a virus with R292K substitution in neuraminidase in cynomolgus macaques compared with I222T substitution.
Journal: Antiviral research
Published: October 06, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026